Recently, Zhao et al. demonstrated that patients with non-alcoholic steatohepatitis had higher expression of CD36, such a phenotype that was linked to an increase in liver inflammation and fibrosis. The gene discussed is CD36; the disease is metabolic dysfunction-associated steatohepatitis.